95 related articles for article (PubMed ID: 12962701)
21. Akt-dependent phosphorylation negatively regulates the transcriptional activity of dHAND by inhibiting the DNA binding activity.
Murakami M; Kataoka K; Fukuhara S; Nakagawa O; Kurihara H
Eur J Biochem; 2004 Aug; 271(16):3330-9. PubMed ID: 15291810
[TBL] [Abstract][Full Text] [Related]
22. Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma.
Sakashita ; Kobayashi H; Satake N; Maseki N; Sakurai M; Izumo T; Isobe M; Kaneko Y
Leukemia; 1998 Jun; 12(6):970-1. PubMed ID: 9639427
[TBL] [Abstract][Full Text] [Related]
23. The murine Tcl1 oncogene: embryonic and lymphoid cell expression.
Narducci MG; Virgilio L; Engiles JB; Buchberg AM; Billips L; Facchiano A; Croce CM; Russo G; Rothstein JL
Oncogene; 1997 Aug; 15(8):919-26. PubMed ID: 9285687
[TBL] [Abstract][Full Text] [Related]
24. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
25. Expression of TCL1 in hematologic disorders.
Roos J; Hennig I; Schwaller J; Zbären J; Dummer R; Burg G; Tobler A; Virgilio L; Croce CM; Fey MF; Borisch B
Pathobiology; 2001; 69(2):59-66. PubMed ID: 11752899
[TBL] [Abstract][Full Text] [Related]
26. Deregulated expression of TCL1 causes T cell leukemia in mice.
Virgilio L; Lazzeri C; Bichi R; Nibu K; Narducci MG; Russo G; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3885-9. PubMed ID: 9520462
[TBL] [Abstract][Full Text] [Related]
27. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
[TBL] [Abstract][Full Text] [Related]
29. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
[TBL] [Abstract][Full Text] [Related]
30. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
[TBL] [Abstract][Full Text] [Related]
31. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
[No Abstract] [Full Text] [Related]
32. The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity.
French SW; Dawson DW; Chen HW; Rainey RN; Sievers SA; Balatoni CE; Wong L; Troke JJ; Nguyen MT; Koehler CM; Teitell MA
Cancer Lett; 2007 Apr; 248(2):198-210. PubMed ID: 16934922
[TBL] [Abstract][Full Text] [Related]
33. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
Yakirevich E; Lefel O; Sova Y; Stein A; Cohen O; Izhak OB; Resnick MB
J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
[TBL] [Abstract][Full Text] [Related]
34. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
Li YM; Zhou BP; Deng J; Pan Y; Hay N; Hung MC
Cancer Res; 2005 Apr; 65(8):3257-63. PubMed ID: 15833858
[TBL] [Abstract][Full Text] [Related]
35. [Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].
Bak M; Hanna E; Csókay B; Bodrogi I; Oláh E
Orv Hetil; 1995 Jan; 136(1):19-25. PubMed ID: 7845662
[TBL] [Abstract][Full Text] [Related]
36. Structure of murine Tcl1 at 2.5 A resolution and implications for the TCL oncogene family.
Petock JM; Torshin IY; Wang YF; Du Bois GC; Croce CM; Harrison RW; Weber IT
Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1545-51. PubMed ID: 11679718
[TBL] [Abstract][Full Text] [Related]
37. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.
Brunet A; Bonni A; Zigmond MJ; Lin MZ; Juo P; Hu LS; Anderson MJ; Arden KC; Blenis J; Greenberg ME
Cell; 1999 Mar; 96(6):857-68. PubMed ID: 10102273
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
Fears S; Chakrabarti SR; Nucifora G; Rowley JD
Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
[TBL] [Abstract][Full Text] [Related]
39. Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt.
Janes SM; Ofstad TA; Campbell DH; Watt FM; Prowse DM
J Cell Sci; 2004 Aug; 117(Pt 18):4157-68. PubMed ID: 15316080
[TBL] [Abstract][Full Text] [Related]
40. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
Porstmann T; Griffiths B; Chung YL; Delpuech O; Griffiths JR; Downward J; Schulze A
Oncogene; 2005 Sep; 24(43):6465-81. PubMed ID: 16007182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
